Paper41398312
The role of ionizing radiation-initiated reactions in targeted activation of chemotherapeutics.
Liu J and 2 others. Nat Rev Chem, 2026. Cited by 5 papers, by iCite.
Cite this record
ConductScience Library. The role of ionizing radiation-initiated reactions in targeted activation of chemotherapeutics. Papers, record 41398312. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41398312
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The role of ionizing radiation-initiated reactions in targeted activation of chemotherapeutics.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Radiation, Ionizing | Major topic |
| Antineoplastic Agents | Major topic |
| Prodrugs | Major topic |
| Humans | |
| Drug Liberation | |
| Water | |
| Animals |
Source PubMed
References75
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 37397557 | Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics. | Genes Dis | 2023 | https://conductscience.org/library/papers/37397557 | PubMed |
| 2 | 21430696 | Strategies to improve radiotherapy with targeted drugs. | Nat Rev Cancer | 2011 | https://conductscience.org/library/papers/21430696 | PubMed |
| 3 | 37704601 | Dual hypoxia-responsive supramolecular complex for cancer target therapy. | Nat Commun | 2023 | https://conductscience.org/library/papers/37704601 | PubMed |
| 4 | 32524819 | Potent and Prolonged Innate Immune Activation by Enzyme-Responsive Imidazoquinoline TLR7/8 Agonist Prodrug Vesicles. | J Am Chem Soc | 2020 | https://conductscience.org/library/papers/32524819 | PubMed |
| 5 | 32385252 | Light-triggered release of conventional local anesthetics from a macromolecular prodrug for on-demand local anesthesia. | Nat Commun | 2020 | https://conductscience.org/library/papers/32385252 | PubMed |
| 6 | 37323693 | Ultrasound-controlled drug release and drug activation for cancer therapy. | Exploration (Beijing) | 2021 | https://conductscience.org/library/papers/37323693 | PubMed |
| 7 | 36048467 | Emerging Strategies in Stimuli-Responsive Prodrug Nanosystems for Cancer Therapy. | ACS Nano | 2022 | https://conductscience.org/library/papers/36048467 | PubMed |
| 8 | 34961986 | Metabolic response to radiation therapy in cancer. | Mol Carcinog | 2022 | https://conductscience.org/library/papers/34961986 | PubMed |
| 9 | 23397358 | Chemotherapy plus radiotherapy versus radiotherapy alone in patients with anaplastic glioma: a systematic review and meta-analysis. | J Cancer Res Clin Oncol | 2013 | https://conductscience.org/library/papers/23397358 | PubMed |
| 10 | 33441727 | Radiation-induced cell cycle perturbations: a computational tool validated with flow-cytometry data. | Sci Rep | 2021 | https://conductscience.org/library/papers/33441727 | PubMed |
| 11 | 37581644 | Nanoscale Metal-Organic Framework with an X-ray Triggerable Prodrug for Synergistic Radiotherapy and Chemotherapy. | J Am Chem Soc | 2023 | https://conductscience.org/library/papers/37581644 | PubMed |
| 12 | 39565960 | Nanoscale Mixed-Ligand Metal-Organic Framework for X-ray Stimulated Cancer Therapy. | J Am Chem Soc | 2024 | https://conductscience.org/library/papers/39565960 | PubMed |
| 13 | 37019890 | Localized nuclear reaction breaks boron drug capsules loaded with immune adjuvants for cancer immunotherapy. | Nat Commun | 2023 | https://conductscience.org/library/papers/37019890 | PubMed |
| 14 | 24347066 | The combination of chemotherapy and radiotherapy towards more efficient drug delivery. | Chem Asian J | 2014 | https://conductscience.org/library/papers/24347066 | PubMed |
| 15 | 36087574 | Radiotherapy-triggered prodrug activation: A new era in precise chemotherapy. | Med | 2022 | https://conductscience.org/library/papers/36087574 | PubMed |
| 16 | 35217798 | Radiation-induced prodrug activation: extending combined modality therapy for some solid tumours. | Br J Cancer | 2022 | https://conductscience.org/library/papers/35217798 | PubMed |
| 17 | 27043181 | Scintillating Nanoparticles as Energy Mediators for Enhanced Photodynamic Therapy. | ACS Nano | 2016 | https://conductscience.org/library/papers/27043181 | PubMed |
| 18 | 36493905 | Nanosensitizer-mediated unique dynamic therapy tactics for effective inhibition of deep tumors. | Adv Drug Deliv Rev | 2023 | https://conductscience.org/library/papers/36493905 | PubMed |
| 19 | 31344330 | Low-Dose X-ray Excited Photodynamic Therapy Based on NaLuF4:Tb3+-Rose Bengal Nanocomposite. | Bioconjug Chem | 2019 | https://conductscience.org/library/papers/31344330 | PubMed |
| 20 | 40210595 | Porphyrin-Engineered 125I-Nanoseeds as a Prototype for Immunogenic Brachytherapy. | J Am Chem Soc | 2025 | https://conductscience.org/library/papers/40210595 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42503675 | Spontaneous Intracellular Formation of Covalent Organic Frameworks via Enzyme-Initiated Cascade Reactions to Boost Cancer Radiotherapy. | J Am Chem Soc | 2026 | https://conductscience.org/library/papers/42503675 | PubMed |
| 42364664 | Design rules for externally triggered drug uncaging under optical and radiolytic regimes. | Eur J Pharm Biopharm | 2026 | https://conductscience.org/library/papers/42364664 | PubMed |
| 42078200 | Radiotherapy meets anticancer metallodrugs. | Med Rev (2021) | 2026 | https://conductscience.org/library/papers/42078200 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41398312
GET https://conductscience.org/api/papers/v1/41398312/references?page=2